Back to search
FDAFDA · Food and drugs·Recall number Z-1400-2017

Remel, Haemophilus Test Medium (Agar) in A) 100 mm REF R01503, and B) 150 mm plates REF R04033,

Published March 15, 2017 · Recall initiated: February 9, 2017

Summary

FDA records medical device Class II recall Z-1400-2017, published March 15, 2017 and initiated February 9, 2017. Recalling firm: Remel Inc; Status: Terminated; Reported quantity: RO4033 - 163, R01503 - 50.; Lot: A) Lot: 978596, 2017-01-30; B) Lot: 978948, 2017/01/30. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Test organisms exhibit poor growth when grown using the test agar. The poor growth can give users incorrect AST zones when performing susceptibility tests.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Remel Inc
Distributor
USA ( nationwide ) Distribution including Puerto Rico and to the states of : AK, AL, AR, AZ, CA, CO, CT, DC, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, NC, ND, NE, NH, NJ, NY, OH, OK, OR, PA, RI, SD, TN, TX, VA, VT, WA, WI, WV and WY.
Lot
A) Lot: 978596, 2017-01-30; B) Lot: 978948, 2017/01/30
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Remel, Haemophilus Test Medium (Agar) in A) 100 mm REF R01503, and B) 150 mm plates REF R04033, recalled?

Yes. FDA published recall Z-1400-2017 on March 15, 2017. Reported hazard: Test organisms exhibit poor growth when grown using the test agar. The poor growth can give users incorrect AST zones when performing susceptibility tests.

What should I do if I have this product?

Voluntary: Firm initiated · Letter